mhurhangee/ep-ind-claims huggingface dataset:
An image forming apparatus connectable to a sheet post-processing apparatus having a function of performing post-processing, the image forming apparatus comprising: an image forming unit configured to form an image on a sheet; an inspection processing unit configured to inspect the image formed on the sheet by said image forming unit; an image reading unit configured to read the image on the sheet conveyed from said image forming unit and configured to transmit image data corresponding to the read image to said inspection processing unit; and a communication unit configured to output a discharge timing signal, generated on the basis of a detection result of an outlet sensor and indicating timing when the sheet is discharged to the post-processing apparatus, to the post-processing apparatus through a signal line, wherein said communication unit is configured to output the discharge timing signal including a first waveform (401a, 421a, 431a) in a case that the sheet determined to be normal by said inspection processing unit is discharged and configured to output the discharge timing signal including a second waveform (401b, 421b, 431b) different from the first waveform in a case that the sheet determined to be abnormal by said inspection processing unit is discharged. an image forming unit configured to form an image on a sheet; an inspection processing unit configured to inspect the image formed on the sheet by said image forming unit; an image reading unit configured to read the image on the sheet conveyed from said image forming unit and configured to transmit image data corresponding to the read image to said inspection processing unit; and a communication unit configured to output a discharge timing signal, generated on the basis of a detection result of an outlet sensor and indicating timing when the sheet is discharged to the post-processing apparatus, to the post-processing apparatus through a signal line, wherein said communication unit is configured to output the discharge timing signal including a first waveform (401a, 421a, 431a) in a case that the sheet determined to be normal by said inspection processing unit is discharged and configured to output the discharge timing signal including a second waveform (401b, 421b, 431b) different from the first waveform in a case that the sheet determined to be abnormal by said inspection processing unit is discharged.
Housing assembly for accommodating electrical storage means for an electric drive of an electrically drivable motor vehicle, comprising: a base tray with a base and a circumferentially closed tray frame, which is produced from a metallic material by forming; a structural frame which comprises a plurality of frame elements (8, 9, 10, 11) connected to each other to form a circumferential frame and a plurality of reinforcing elements extending between two frame elements (8, 9), wherein the frame elements (8, 9, 10, 11) and the reinforcing elements are each made of a steel material and are connected to each other to form the structural frame, and wherein the structural frame is connected to the base tray; wherein the yield strength of the steel material of the frame elements (8, 9, 10, 11) and reinforcing elements is at least 10 % greater than the yield strength of the metallic material of the tray frame; a cover which is releasably connectable to the tray frame, wherein the tray frame and the cover enclose a receiving space for electrical storage means, characterised in that the structural frame is arranged in the base tray inside the tray frame. a base tray with a base and a circumferentially closed tray frame, which is produced from a metallic material by forming; a structural frame which comprises a plurality of frame elements (8, 9, 10, 11) connected to each other to form a circumferential frame and a plurality of reinforcing elements extending between two frame elements (8, 9), wherein the frame elements (8, 9, 10, 11) and the reinforcing elements are each made of a steel material and are connected to each other to form the structural frame, and wherein the structural frame is connected to the base tray; wherein the yield strength of the steel material of the frame elements (8, 9, 10, 11) and reinforcing elements is at least 10 % greater than the yield strength of the metallic material of the tray frame; a cover which is releasably connectable to the tray frame, wherein the tray frame and the cover enclose a receiving space for electrical storage means, characterised in that the structural frame is arranged in the base tray inside the tray frame.
A remote-control unit having an input transducer, an output transducer, and a processor adapted for setting a volume of an output from the output transducer, the remote-control unit is adapted for controlling a hearing assistive device by sending a control signal with instructions on an audio carrier, wherein the processor is adapted for: - activating the input transducer for receiving environmental sound, - analyzing the environmental sound, characterized in that the processor furthermore is adapted for: - determining and setting the volume of the output from the output transducer based on the environmental sound, and - outputting the control signal with instructions on the audio carrier at the set volume via the output transducer. - activating the input transducer for receiving environmental sound, - analyzing the environmental sound, - determining and setting the volume of the output from the output transducer based on the environmental sound, and - outputting the control signal with instructions on the audio carrier at the set volume via the output transducer.
A solid composition comprising a compound, or a pharmaceutically acceptable salt thereof, in an amorphous form, a pharmaceutically acceptable hydrophilic polymer; and optionally a pharmaceutically acceptable surfactant, wherein said compound is selected from the group consisting of: dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-((2S,5S)-l-(4- tert -butylphenyl)pyrrolidine-2,5-diyl)bis(4,1-phenylene))bis(azanediyl)bis(oxomethylene)bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate (Compound I A), methyl [ -1-{ -2-[4-(4-{5-(4-{2-[ -1-{ -2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}phenyl)-1-[6-(piperidin-1-yl)pyridin-3-yl]-1H-pyrrol-2-yl}phenyl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate (Compound I B), methyl {(2 S,3 R)-1-[(2 S)-2-{6-[(2 R,5 R)-1-(4- tert -butylphenyl)-5-(2-{(2 S)-1-[ N- (methoxycarbonyl)- O -methyl-L-threonyl]pyrrolidin-2-yl}-1 H- benzimidazol-6-yl)pyrrolidin-2-yl]-1 H -benzimidazol-2-yl}pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl}carbamate (Compound I C), and methyl { -1-[ -2-{5-[(2R,SR)-1-[2,5-difluoro-4-(trifluoromethyl)phenyl]-5-{2-[(2 S)-1- { -2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-benzimidazol-5-yl}pyrrolidin-2-yl]-1H-benzimidazol-2-yl}pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate (Compound I D), and wherein said compound or salt, and said polymer, are in a solid dispersion. a compound, or a pharmaceutically acceptable salt thereof, in an amorphous form, a pharmaceutically acceptable hydrophilic polymer; and optionally a pharmaceutically acceptable surfactant, dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-((2S,5S)-l-(4- tert -butylphenyl)pyrrolidine-2,5-diyl)bis(4,1-phenylene))bis(azanediyl)bis(oxomethylene)bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate (Compound I A), methyl [ -1-{ -2-[4-(4-{5-(4-{2-[ -1-{ -2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}phenyl)-1-[6-(piperidin-1-yl)pyridin-3-yl]-1H-pyrrol-2-yl}phenyl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate (Compound I B), methyl {(2 S,3 R)-1-[(2 S)-2-{6-[(2 R,5 R)-1-(4- tert -butylphenyl)-5-(2-{(2 S)-1-[ N- (methoxycarbonyl)- O -methyl-L-threonyl]pyrrolidin-2-yl}-1 H- benzimidazol-6-yl)pyrrolidin-2-yl]-1 H -benzimidazol-2-yl}pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl}carbamate (Compound I C), and methyl { -1-[ -2-{5-[(2R,SR)-1-[2,5-difluoro-4-(trifluoromethyl)phenyl]-5-{2-[(2 S)-1- { -2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-benzimidazol-5-yl}pyrrolidin-2-yl]-1H-benzimidazol-2-yl}pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate (Compound I D), and
Method for operating a photovoltaic system, which comprises solar panels, a main contactor for short-circuiting the solar panels, at least one DC-DC converter and an intermediate DC circuit, characterised in that an H-bridge-shaped buck-boost converter (S1, S2, S3, S4, D1, D2, D3, D4, SP) with a coil and four switching elements (S1, S2, S3, S4), which are assigned a freewheeling diode (D1, D2, D3, D4) in each case, is used as the DC-DC converter, and that in a transition phase between unloaded and loaded state of the solar panels, the switching elements (S1, S2, S3, S4) of the DC-DC converter are brought into a switching state which forms a permanent current path between the output of the solar panels and the intermediate circuit, wherein the current path is closed by way of the closed main contactor, by way of a closed switching element, which is arranged on the solar panel side on a high-side of the H-bridge-shaped DC-DC converter, by way of the coil of the DC-DC converter and by way of a freewheeling diode, which is assigned to a switching element arranged on the intermediate circuit side on the high-side of the H-bridge-shaped DC-DC converter.
A method of thermal management in a computing device using a management controller, comprising: obtaining, via at least two virtual management controllers (307A, 307B), monitoring information of one or more thermally sensitive components (308A, 308B) of the computing device unable to communicate directly to the management controller, the monitoring information comprising temperature information of the one or more thermally sensitive components (308A, 308B); transmitting, via the at least two virtual management controllers (307A, 307B), the monitoring information to the management controller via a system interface of the management controller; adjusting, via the management controller, operation of at least one thermal management component of the computing device tethered to the management controller, managing, by a virtual baseboard management controller manager, messages received at the management controller from at least two virtual management controllers (307A, 307B), and the at least two virtual management controllers obtaining monitoring information from at least two different thermally sensitive components (308A, 308B); and wherein the at least two virtual management controllers run on a hypervisor that runs on a CPU of the computing device, and the CPU is connected to the thermally sensitive components. obtaining, via at least two virtual management controllers (307A, 307B), monitoring information of one or more thermally sensitive components (308A, 308B) of the computing device unable to communicate directly to the management controller, the monitoring information comprising temperature information of the one or more thermally sensitive components (308A, 308B); transmitting, via the at least two virtual management controllers (307A, 307B), the monitoring information to the management controller via a system interface of the management controller; adjusting, via the management controller, operation of at least one thermal management component of the computing device tethered to the management controller, managing, by a virtual baseboard management controller manager, messages received at the management controller from at least two virtual management controllers (307A, 307B), and the at least two virtual management controllers obtaining monitoring information from at least two different thermally sensitive components (308A, 308B); and wherein the at least two virtual management controllers run on a hypervisor that runs on a CPU of the computing device, and the CPU is connected to the thermally sensitive components.
Device for connecting two tubular objects, the device comprising a socket housing and a sleeve-shaped element, wherein the socket housing comprises a sleeve section with an insertion opening and at least one radially continuous recess, wherein the sleeve-shaped element is formed complementary to the insertion opening for insertion into the insertion opening, wherein the sleeve section comprises at least one first engagement element and the sleeve-shaped element comprises at least one second engagement element, which correspond to one another in the sleeve section for locking the sleeve-shaped element and which are movable from an open relative position into a locked relative position, characterised in that the sleeve-shaped element comprises an indicator element extending radially outwardly from the sleeve-shaped element, the indicator element projecting through the at least one recess in the open relative position, the indicator element being moved radially inwardly by a component (28, 44) arranged in the recess in the locked relative position and being completely concealed by the component.
Chassis component for a wheel suspension, comprising a strut arrangement which has at least one strut and which is configured as a profile part with an open cross-sectional shape, wherein the at least one strut comprises a profile base and two wall portions emanating therefrom, wherein a joint point for receiving two movably interconnected joint parts (13, 30), a first joint part having a spherical joint body and a second joint part rotatably and/or pivotably receiving the joint body, is provided at at least one end of the strut, wherein the wall portions have, arranged opposite one another in the region of the at least one joint point, a first joint receiving opening and a second joint receiving opening, characterized in that the joint body is positioned between the first and the second joint receiving opening (6, 7) by way of a ring-segment-shaped fastening element arranged on the joint body, wherein the joint receiving openings (6, 7) and the joint body positioned therebetween are integrated into a joint housing which is produced by overmoulding and which forms the second joint part.
An antagonist of TLR7 and/or TLR9 comprising the structure 5'-N p N 3 N 2 N 1 C*G1N 1 N 2 N 3 N z N 4 N 5 -3', wherein C*G1 is an oligonucleotide motif wherein C* is 5-Me-dC, and G1 is 7-deaza-dG; N 1 -N 2, at each occurrence, is independently a 2'-O-Me-ribonucleotide; N 3, at each occurrence, is independently a nucleotide; N 1 -N 3, at each occurrence, is independently a nucleotide; N p and N z, at each occurrence, is independently a nucleotide; N 4 -N 5, at each occurrence, is independently a 2'-O-Me-ribonucleotide; p is 5; and z is 3; provided that said antagonist contains less than 3 consecutive guanosines, for use in a method for therapeutically treating an autoimmune disorder, a cancer or an inflammatory disorder in a mammal, wherein the autoimmune disorder is selected from lupus erythematosus, multiple sclerosis, type I diabetes mellitus, irritable bowel syndrome, Crohn's disease, psoriasis, rheumatoid arthritis, septic shock, alopecia universalis, acute disseminated encephalomyelitis, Addison's disease, ankylosing spondylitis, antiphospholipid antibody syndrome, autoimmune hemolytic anemia, autoimmune hepatitis, Bullous pemphigoid, Chagas disease, chronic obstructive pulmonary disease, coeliac disease, dermatomyositis, endometriosis, Goodpasture's syndrome, Graves' disease, Guillain-Barre syndrome, Hashimoto's disease, hidradenitis suppurativa, idiopathic thrombocytopenic purpura, interstitial cystitis, morphea, myasthenia gravis, narcolepsy, neuromyotonia, pemphigus, pernicious anaemia, polymyositis, primary biliary cirrhosis, schizophrenia, Sjögren's syndrome, temporal arteritis ("giant cell arteritis"), vasculitis, vitiligo, vulvodynia and Wegener's granulomatosis; wherein the inflammatory disorder is selected from the group consisting of airway inflammation, asthma, chronic inflammation, chronic prostatitis, glomerulonephritis, Behçet's disease, hypersensitivities, inflammatory bowel disease, reperfusion injury, rheumatoid arthritis, transplant rejection, ulcerative colitis, uveitis, conjunctivitis and vasculitis; and wherein said antagonist is comprised in a pharmaceutical composition, said pharmaceutical composition further comprising a pharmaceutically acceptable carrier selected from the group consisting of an excipient, a diluent, a filler, a salt, a buffer, a stabilizer, a solubilizer, an oil, a lipid, a lipid containing vesicle and microspheres.
Testing device for a motor vehicle, comprising a chassis dynamometer comprising: ▪ at least one first roller rotating on itself, pivotably connected with a chassis connected to the testing device, arranged so that its periphery is in frictional contact with the circumference of at least one driving wheel of the vehicle, ▪ dynamic means arranged in order to transmit a torque to the at least one first roller at least partially simulating the reaction of the road for the tested vehicle, the dynamic means comprising an electric machine capable of operating selectively in generator mode and in motor mode, and ▪ a loading machine, in particular a Foucault current brake comprising a shaft that is rotary with respect to the chassis, characterized in that it comprises control means that can be actuated in order to operate selectively - the loading machine simultaneously with the electric machine in generator mode or - the loading machine simultaneously with the electric machine in motor mode. ▪ at least one first roller rotating on itself, pivotably connected with a chassis connected to the testing device, arranged so that its periphery is in frictional contact with the circumference of at least one driving wheel of the vehicle, ▪ dynamic means arranged in order to transmit a torque to the at least one first roller at least partially simulating the reaction of the road for the tested vehicle, the dynamic means comprising an electric machine capable of operating selectively in generator mode and in motor mode, and ▪ a loading machine, in particular a Foucault current brake comprising a shaft that is rotary with respect to the chassis, - the loading machine simultaneously with the electric machine in generator mode or - the loading machine simultaneously with the electric machine in motor mode.
A method performed by a wireless device for managing radio resources in the wireless device, the method comprising: receiving a message configuring a radio bearer for use by the wireless device; checking the message for a ciphering configuration setting enabling or disabling ciphering for the radio bearer; and performing at least one of enabling or disabling ciphering for the radio bearer in accordance with the received message; wherein the message configures a plurality of radio bearers for the wireless device; and wherein checking the message for a ciphering configuration setting for the radio bearer comprises checking a pdcp-Config Information Element specific to the radio bearer; and wherein checking the message for a ciphering configuration setting for the radio bearer further comprises checking after the extension marker of the pdcp-Config Information Element. receiving a message configuring a radio bearer for use by the wireless device; checking the message for a ciphering configuration setting enabling or disabling ciphering for the radio bearer; and performing at least one of enabling or disabling ciphering for the radio bearer in accordance with the received message; wherein the message configures a plurality of radio bearers for the wireless device; and wherein checking the message for a ciphering configuration setting for the radio bearer comprises checking a pdcp-Config Information Element specific to the radio bearer; and wherein checking the message for a ciphering configuration setting for the radio bearer further comprises checking after the extension marker of the pdcp-Config Information Element.
Device for accepting and transporting at least one wheelset of a rail vehicle, comprising: - a first side part and a second side part, that are spaced apart from one another in the transverse direction, - whereby the two side parts (2, 2') are connected to one another, - whereby both side parts (2, 2') each have a upper structure (4, 4') and a lower structure (3, 3'), - whereby both lower structures (3, 3') have at least one track wheel (5, 5', 5", 5′′′), with which the device can be moved in the longitudinal direction and - whereby both upper structures (4, 4') have a receptacle (6, 6'), in which a wheel of a wheelset can be accepted, characterised in that the upper structure (4, 4') of a side part (2, 2') is rotatably mounted relative to the lower structure (3, 3') of the same lower structure (2, 2'). - a first side part and a second side part, that are spaced apart from one another in the transverse direction, - whereby the two side parts (2, 2') are connected to one another, - whereby both side parts (2, 2') each have a upper structure (4, 4') and a lower structure (3, 3'), - whereby both lower structures (3, 3') have at least one track wheel (5, 5', 5", 5′′′), with which the device can be moved in the longitudinal direction and - whereby both upper structures (4, 4') have a receptacle (6, 6'), in which a wheel of a wheelset can be accepted, characterised in that the upper structure (4, 4') of a side part (2, 2') is rotatably mounted relative to the lower structure (3, 3') of the same lower structure (2, 2'). of a wheelset can be accepted, characterised in that the upper structure (4, 4') of a side part (2, 2') is rotatably mounted relative to the lower structure (3, 3') of the same lower structure (2, 2').
A genetically altered carotenoid-producing organism comprising at least one chromoplast-containing cell having reduced expression or activity of Ziso protein comprising an amino acid sequence at least 70%, 75%, 80%, 85% or 95% homologous to the amino acids sequence set forth in SEQ ID NO:3 compared to a corresponding non-altered organism having non-altered expression of the Ziso protein, wherein the genetically altered organism has an elevated content of at least one carotenoid selected from the group consisting of phytoene, phytofluene, zeta carotene and combinations thereof compared to the corresponding non-altered organism, said genetically modified organism being selected from the group consisting of a plant, an alga and a cyanobacterium.